DIGITAL EDITION

ARCHIVES

Category: Past Articles

Blood–Brain Barrier: COVID-19, Pandemics, and Cytokine Norms

by Atmaram Yarlagadda, MD; Samuel L. Preston, DO; Rachel P. Jeyadhas, MD; Adam Edward Lang, PharmD; Rasha Hammamieh, PhD; And Anita H. Clayton, MD Dr. Yarlagadda is the Installation Director

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with

Effects of Prismatic Lenses on Lateral Axial Dystonia in Parkinson’s Disease: A Pilot Study

by Michele Meglio, PhD Student; Enrica Olivola, MD, PhD; Marco Santilli, BSC; Francesco Lena, MSC, PhD; Diego Centonze, MD, PhD; Matteo Bologna, MD, PhD; and Nicola Modugno, MD, PhD Dr.

Transcranial Magnetic Stimulation in Treatment of Adolescent Attention Deficit/Hyperactivity Disorder: A Narrative Review of Literature

[protected]by Aksha M. Memon, MD, MPH Dr. Memon is an Assistant Professor with the Department of Foundational Medical Studies at Oakland University William Beaumont School of Medicine in Rochester Hills,

Minor Head Injury Might Cause Treatable Dementia Due to Severe Hyponatremia

by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Sunlight Brain Research Center in Hofu, Yamaguchi, Japan. FUNDING: No funding was provided for this study. DISCLOSURES: The author has

Editorial Message and Issue Highlights–Vol. 17, No. 10–12, October–December 2020

Dear Colleagues: Welcome to the October–December 2020 edition of Innovations in Clinical Neuroscience (ICNS). For 2020’s fourth and final quarterly issue of ICNS, we start with a letter to the

Letters to the Editor: Nonresponsive myasthenia is suspicious for congenital myasthenic syndrome or myopathy

Dear Editor: We read the excellent article by Diaz-Abad et al1 about a 54-year-old male patient with double seronegative myasthenia gravis. In the article, Diaz et al1 explained the patient

Intellectual Disability in Morocco: A Pilot Study

by Yousra BENMAKHLOUF, PhD; Zeineb ZIAN, PhD; Kaoutar BEN MAKHLOUF; Naima GHAILANI NOUROUTI, PR; Amina BARAKAT, PR; and Mohcine BENNANI MECHITA PR Drs. Benmakhlouf, Zian, Ghailani Nourouti, Barakat, and Bennani

Who Will Pay for Robotic Rehabilitation? The Growing Need for a Cost-effectiveness Analysis

by Rocco Salvatore Calabrò, MD, PhD; Claudia Müller-Eising, Dr. jur.; Maria Letizia Diliberti; Alfredo Manuli, MSc; Francesca Parrinello, MD; Giuseppe Rao, MD; Vincenzo Barone, Dr. jur.; and Tamara Civello Drs.

Pilot Mental Health Survey, Nepal: Lessons Learned for Survey Design and Instrumentation

by Sushma Dahal, MPH; Meghnath Dhimal, PhD; Sagun Ballav Pant, MD; Pawan Sharma, MD; Kedar Marahatta, MD; Nagendra Luitel, MA; Suraj Shakya, PhD; Sweta Labh, BSc Nursing; Saroj Prasad Ojha,

Multiple Cellular Therapies Along with Neurorehabilitation in Spastic Diplegic Cerebral Palsy: A Case Report

by Alok Sharma, MCh; Nandini Gokulchandran, MD; Pooja Kulkarni, MSc; Sandhya Kiran Mullangi, MPT; Khushboo Bhagawanani, BPT; Vishal Ganar, MPhil; Hemangi Sane, MD; and Prerna Badhe, MD Drs. Sharma and

Neuroleptic Malignant Syndrome: Can Be an Unrecognized Chronic Fatal Disease

by Kulwant Buttar, MD; Eileen Trigoboff, RN, DNS; and Jeffery J Grace, MD Dr. Buttar is with the Buffalo Psychiatric Center in Buffalo New York. Dr. Trigoboff is with the

Editorial Message and Issue Highlights–Vol. 17, No. 7–9, July–September 2020

Dear Colleagues: Welcome to the July–September 2020 edition of Innovations in Clinical Neuroscience (ICNS). For 2020’s third quarterly issue of ICNS, we start with two letters to the editor. First,

Meralgia Paresthetica Successfully Treated with Palmithoylethanolamide

by Rocco Salvatore Calabrò MD, PhD; Carmela Casella, MD; Alfredo Manuli, MSc; David Militi, MD; and Giuseppe Gervasi, MD, PhD Drs. Calabrò and Manuli are with IRCCS Centro Neurolesi “Bonino